Prestige Wealth Management Group LLC Abb Vie Inc. Transaction History

Prestige Wealth Management Group LLC

$460 Million
Q3 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 4,123 shares of ABBV stock, worth $723,916. This represents 0.18% of its overall portfolio holdings.

Number of Shares

4,123

Previous 3,739 10.27%

Holding current value

$723,916

Previous $641,000 26.99%

% of portfolio

0.18%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $62,914 - $76,542	384 Added 10.27%	4,123 $814,000
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $478,920 - $559,271	3,094 Added 479.69%	3,739 $641,000
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $42,831 - $48,802	-268 Reduced 29.35%	645 $117,000
Q4 2023 Apr 26, 2024	SELL	$137.6 - $154.97 $11,558 - $13,017	-84 Reduced 8.43%	913 $141,000
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $11,558 - $13,017	-84 Reduced 8.43%	913 $141,000
Q3 2023 Apr 26, 2024	SELL	$133.59 - $154.65 $5,610 - $6,495	-42 Reduced 4.04%	997 $148,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $5,610 - $6,495	-42 Reduced 4.04%	997 $148,000
Q2 2023 Apr 26, 2024	SELL	$132.51 - $164.9 $655,924 - $816,255	-4,950 Reduced 82.65%	1,039 $139,000
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $655,924 - $816,255	-4,950 Reduced 82.65%	1,039 $139,000
Q1 2023 Apr 26, 2024	BUY	$144.61 - $166.54 $772,795 - $889,989	5,344 Added 828.53%	5,989 $954,000
Q1 2023 May 16, 2023	BUY	$144.61 - $166.54 $693,838 - $799,058	4,798 Added 402.85%	5,989 $954,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $582,423 - $698,478	-4,211 Reduced 77.95%	1,191 $192,000
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $66,299 - $76,041	494 Added 10.07%	5,402 $725,000
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $31,377 - $39,890	228 Added 4.87%	4,908 $751,000
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $460,214 - $570,996	3,487 Added 292.29%	4,680 $759,000
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $1,718 - $2,174	16 Added 1.36%	1,193 $161,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $66,925 - $75,970	629 Added 114.78%	1,177 $127,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $613 - $675	6 Added 1.11%	548 $60,000
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $14,568 - $19,669	181 Added 50.14%	542 $58,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $103,525 - $138,531	-1,411 Reduced 79.63%	361 $36,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $12,642 - $19,166	196 Added 12.44%	1,772 $135,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $8,944 - $11,191	124 Added 8.54%	1,576 $140,000
Q2 2019 Aug 16, 2019	BUY	$65.7 - $83.98 $1,116 - $1,427	17 Added 1.18%	1,452 $105,000
Q1 2019 Aug 16, 2019	BUY	$77.14 - $90.79 $73,283 - $86,250	950 Added 195.88%	1,435 $115,000
Q4 2018 Apr 16, 2019	BUY	$77.85 - $96.01 $37,757 - $46,564	485 New	485 $45,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Abb Vie Inc. Transaction History